Cohen Matthew Robert 4
4 · GenMark Diagnostics, Inc. · Filed Jan 5, 2012
Insider Transaction Report
Form 4
Cohen Matthew Robert
SVP, Gen Counsel & Secretary
Transactions
- Award
Common Stock
2012-01-03$4.38/sh+26,856$117,629→ 26,856 total - Award
Stock Option (Right to Buy)
2012-01-03+42,500→ 42,500 totalExercise: $4.38Exp: 2022-01-03→ Common Stock (42,500 underlying)
Footnotes (2)
- [F1]25% of the shares vest on November 7, 2012 and the remaining restricted stock vests in 12 quarterly installments thereafter.
- [F2]25% of the option shares vest and become exercisable on November 7, 2012 and the remaining option shares vest and become exercisable in 36 monthly installments thereafter.